digital-health
Every record this desk has filed under digital-health, newest first, each with the number of sources it can still show you.
FDA final guidance explains when prescription-drug apps belong in a medicine's official labeling
FDA released final guidance on October 20 about software disseminated by or on behalf of prescription-drug sponsors, followed by an October 21 Federal Register notice. It addresses app content, prescribing information and submissions for FDA review. The guidance is nonbinding, and the notice permits comments at any time rather than setting a new closing date.
Also filed underhealthprescription-drugslabelingfdafederal-register
A record appears here because it carries digital-health in its own tags. If a record you expected is missing, it was filed under a different subject — the full list is on the topics index.